MedWatch

Newly elected chairman: Full speed ahead

Florian Schönharting, CEO of NB Capital, has been named the new chairman of the board in a Danish biotech company. One of his most important tasks is to kick things into gear, according to himself.

Foto: Franco.Giovanella / Stock.Xchng

“…each day that passes is a lost day of peak sales…”

The new chairman of the Danish biotech company Forward Pharma, CEO Florian Schönharting of Nordic Biotech/NB Capital - which owns the company along with Rosetta Capital – makes no bones about his intentions to use his new influence as chairman. Schönharting has taken over the reins from Wyle David Solomon in 2012.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier